Bristol-Myers Squibb Current Ratio 2006-2018 | BMY

Current and historical current ratio for Bristol-Myers Squibb (BMY) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Bristol-Myers Squibb current ratio for the three months ending September 30, 2018 was 1.53.
Bristol-Myers Squibb Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $14.87B $9.69B 1.53
2018-06-30 $13.87B $9.88B 1.41
2018-03-31 $14.65B $9.62B 1.52
2017-12-31 $14.85B $9.56B 1.55
2017-09-30 $15.05B $9.44B 1.59
2017-06-30 $14.32B $9.02B 1.59
2017-03-31 $13.62B $8.49B 1.60
2016-12-31 $13.70B $8.84B 1.55
2016-09-30 $13.20B $9.00B 1.47
2016-06-30 $12.30B $7.89B 1.56
2016-03-31 $11.22B $7.60B 1.48
2015-12-31 $10.42B $8.02B 1.30
2015-09-30 $12.93B $7.16B 1.81
2015-06-30 $13.06B $7.44B 1.76
2015-03-31 $14.93B $7.69B 1.94
2014-12-31 $14.61B $8.46B 1.73
2014-09-30 $14.18B $8.10B 1.75
2014-06-30 $14.06B $7.80B 1.80
2014-03-31 $14.01B $7.52B 1.86
2013-12-31 $18.92B $12.44B 1.52
2013-09-30 $10.63B $8.28B 1.28
2013-06-30 $10.49B $8.35B 1.26
2013-03-31 $10.08B $8.41B 1.20
2012-12-31 $9.52B $8.28B 1.15
2012-09-30 $9.28B $8.20B 1.13
2012-06-30 $11.01B $6.99B 1.58
2012-03-31 $11.77B $7.21B 1.63
2011-12-31 $15.32B $7.78B 1.97
2011-09-30 $14.87B $7.31B 2.03
2011-06-30 $14.78B $7.41B 1.99
2011-03-31 $13.30B $6.76B 1.97
2010-12-31 $13.27B $6.74B 1.97
2010-09-30 $14.38B $6.28B 2.29
2010-06-30 $12.98B $5.91B 2.20
2010-03-31 $12.53B $6.02B 2.08
2009-12-31 $13.96B $6.31B 2.21
2009-09-30 $13.39B $7.39B 1.81
2009-06-30 $14.57B $6.74B 2.16
2009-03-31 $15.38B $6.63B 2.32
2008-12-31 $14.70B $6.71B 2.19
2008-09-30 $14.78B $6.95B 2.13
2008-06-30 $12.84B $8.64B 1.49
2008-03-31 $10.58B $8.44B 1.25
2007-12-31 $10.10B $8.40B 1.20
2007-09-30 $10.59B $8.05B 1.32
2007-06-30 $11.54B $6.69B 1.73
2007-03-31 $10.56B $6.31B 1.67
2006-12-31 $10.30B $6.50B 1.59
2006-09-30 $11.65B $6.17B 1.89
2006-06-30 $11.80B $5.83B 2.03
2006-03-31 $11.58B $6.00B 1.93
2005-12-31 $12.28B $6.89B 1.78
2005-09-30 $10.15B $6.62B 1.53
2005-06-30 $9.35B $6.63B 1.41
2005-03-31 $12.66B $7.85B 1.61
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $87.290B $20.776B
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $396.345B 18.58
Pfizer (PFE) United States $262.998B 14.83
Merck (MRK) United States $205.854B 17.84
Novartis AG (NVS) Switzerland $204.655B 17.49
AbbVie (ABBV) United States $134.597B 11.95
Eli Lilly (LLY) United States $122.680B 21.57
Sanofi (SNY) France $112.713B 13.96
Novo Nordisk (NVO) Denmark $111.107B 18.04
AstraZeneca (AZN) United Kingdom $103.342B 12.83
GlaxoSmithKline (GSK) United Kingdom $101.256B 13.61